Article Text

This article has a correction. Please see:

other Versions

PDF
Treatment of chronic hepatitis C complicated by mixed cryoglobulinemia with new protease inhibitor, sofosbuvir
  1. Jonathan G Stine,
  2. Scott Cornella,
  3. Neeral L Shah
  1. Correspondence to Dr Jonathan G Stine, University of Virginia, USA; jgs9f{at}virginia.edu

Statistics from Altmetric.com

Article citation: Saadoun D, Rigon MR, Thibault V, et al. Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24. Ann Rheum Dis 2014;73:831–7.

The lack of data showing the effective clearance of cryoglobulins with the addition of direct acting antiviral drugs is problematic, where close to 50% of patients with chronic hepatitis C (HCV) have cryoglobulinemia.1 The original article by Saadoun et al.2 is timely and sheds light on this large subset of chronic HCV …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Correction
    BMJ Publishing Group Ltd and European League Against Rheumatism